ÀÇ·á¹ýÀÎ ÀÌ¿øÀÇ·áÀç´Ü
EDTA tube
÷°¡Á¦ K2 EDTA
ÇØ´ç°Ë»ç CBC, ABO, Rh, ABO Subtyping, Diff Count, Eosinophil Count, ESR, DAT,Du test, Reti, Malaria, HbAIc, PB morphology
°Ëü·® 3mL
º¸°ü ¿ë±â: ½Ç¿Â, äÇ÷ ÈÄ ³ÃÀå
Âü°í»çÇ× Ã¤Ç÷ ÈÄ Ç×ÀÀ°íÁ¦¿Í ÃæºÐÈ÷ È¥ÇÕ

´Ý±â

°Ë»çÇ׸ñ

ÃֽŠ°Ë»çÇ׸ñ°ú °Ë»çÆгÎÀ» È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.

°Ë»çÇ׸ñ Á¶È¸

FMR1 »ï¿°±â ¹Ýº¹(Fragile X)

Àμâ
°Ë»çºÐ¾ß
ºÐÀÚÀ¯Àü°Ë»ç
: À¯Àü¼º(germline) À¯ÀüÀÚ °Ë»ç
°Ë»çÄÚµå
A6545
ºÐ·ù¹øÈ£
³ª580³ª(2)(³ª)
º¸ÇèÄÚµå
C5803126Z
°Ë»ç¹æ¹ý
PCR-Fragment analysis
°Ë»çÀÏ
¿ù-±Ý
¼Ò¿äÀÏ
2ÀÏ
°Ë»ç¼ö°¡
£Ü117,230

*Áú°¡»ê·á¸¦ Æ÷ÇÔÇÏÁö ¾Ê½À´Ï´Ù.
°ËüÁ¾·ù

EDTA tube

°Ëü·® 3mL
°Ëüº¸°ü ³ÃÀå
°Ëü¾ÈÁ¤¼º ½Ç¿Â: 1ÀÏ
³ÃÀå: 7ÀÏ
Âü°íÄ¡
ÀÓ»óÀûÀÇÀÇ Fragile X ÁõÈıºÀº X ¿°»öü »óÀÇ FMR1 À¯ÀüÀÚ ³»ÀÇ CGG ¹Ýº¹È½¼ö°¡ °úµµÇÏ°Ô Áõ°¡ÇÏ´Â »ï¿°±â ¹Ýº¹ÁúȯÀ¸·Î, Áö´ÉÀúÇÏ, ÀÚÆó, ÇнÀÀå¾Ö µîÀÇ Áõ»óÀ» º¸ÀÌ´Â ÁúȯÀÌ´Ù. Full mutation (>200ȸ)ÀÌ ÀÖ´Â ³²¼ºÀº ´ëºÎºÐ ÀÌ ÁúȯÀ¸·Î ÀÎÇÑ Á¤½ÅÁöü³ª ÇൿÀå¾Ö¸¦ ³ªÅ¸³»¸ç, ¿©¼ºÀº ³²ÀÚ¿¡ ºñÇØ Áõ»óÀÌ ½ÉÇÏÁö ¾Ê°í Àý¹Ý Á¤µµ¿¡¼­ Áö´ÉÀå¾Ö ¹× ÀÓ»ó¾ç»óÀ» ³ªÅ¸³½´Ù. ¼¼´ë°¡ °ÅµìµÉ¼ö·Ï ¹Ýº¹È½¼ö°¡ Áõ°¡ÇÏ°í Ç¥ÇöÇüÀÌ ½ÉÇØÁö´Â ¾ç»óÀ» º¸ÀδÙ. ¶ÇÇÑ Premutation carrier (55-200ȸ) ¿©¼ºÀº FXPOI (fragile x associated premature ovarian insufficiency)³ª FXTAS (fragile x associated tremor/ataxia syndrome)°¡ ¹ß»ýÇÒ À§ÇèÀÌ ÀÖÀ¸¹Ç·Î ÃßÀû°üÂûÀÌ ÇÊ¿äÇÏ´Ù.
ÁÖÀÇ»çÇ×
Çʼö¼­·ù À¯ÀüÀڰ˻絿ÀǼ­ºÐÀÚÀ¯Àü°Ë»çÀÇ·Ú¼­
ÃֽŰø¹®